These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 37938624)

  • 1. A novel in silico scaffold-hopping method for drug repositioning in rare and intractable diseases.
    Tanabe M; Sakate R; Nakabayashi J; Tsumura K; Ohira S; Iwato K; Kimura T
    Sci Rep; 2023 Nov; 13(1):19358. PubMed ID: 37938624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug repositioning trends in rare and intractable diseases.
    Sakate R; Kimura T
    Drug Discov Today; 2022 Jul; 27(7):1789-1795. PubMed ID: 35104621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Forging New Scaffolds from Old: Combining Scaffold Hopping and Hierarchical Virtual Screening for Identifying Novel Bcl-2 Inhibitors.
    Kanakaveti V; Rathinasamy S; Rayala SK; Gromiha M
    Curr Top Med Chem; 2019; 19(13):1162-1172. PubMed ID: 31210110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. De Novo Prediction of Drug Targets and Candidates by Chemical Similarity-Guided Network-Based Inference.
    Vigil-Vásquez C; Schüller A
    Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A multi-reference poly-conformational method for
    Alexandrov V; Kirpich A; Kantidze O; Gankin Y
    PeerJ; 2022; 10():e14252. PubMed ID: 36447514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of potential Toxoplasma gondii CDPK1 inhibitors with new scaffolds based on the combination of QSAR and scaffold-hopping method with in vitro validation.
    Zhang P; Jia L; Tian Y; Xi L; Duan R; Chen X; Xiao J; Yao X; Lan J; Li S
    Chem Biol Drug Des; 2020 May; 95(5):476-484. PubMed ID: 31436911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BEAR: A Novel Virtual Screening Method Based on Large-Scale Bioactivity Data.
    Kwon Y; Park S; Lee J; Kang J; Lee HJ; Kim W
    J Chem Inf Model; 2023 Mar; 63(5):1429-1437. PubMed ID: 36821004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug target gene-based analyses of drug repositionability in rare and intractable diseases.
    Sakate R; Kimura T
    Sci Rep; 2021 Jun; 11(1):12338. PubMed ID: 34117295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Scaffold hopping computational approach for searching novel β-lactamase inhibitors].
    Beshnova DA; Carolan C; Grigorenko VG; Rubtsova MY; Gbekor E; Lewis J; Lamzin VS; Egorov AM
    Biomed Khim; 2019 Oct; 65(6):468-476. PubMed ID: 31876517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repurposing of Benzimidazole Scaffolds for HER2 Positive Breast Cancer Therapy: An
    Jubie S; Durai U; Latha S; Ayyamperumal S; Wadhwani A; Prabha T
    Curr Drug Res Rev; 2021; 13(1):73-83. PubMed ID: 32955008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lead generation of cysteine based mesenchymal epithelial transition (c-Met) kinase inhibitors: Using structure-based scaffold hopping, 3D-QSAR pharmacophore modeling, virtual screening, molecular docking, and molecular dynamics simulation.
    Raafat A; Mowafy S; Abouseri SM; Fouad MA; Farag NA
    Comput Biol Med; 2022 Jul; 146():105526. PubMed ID: 35487125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug Repositioning for Cancer Therapy Based on Large-Scale Drug-Induced Transcriptional Signatures.
    Lee H; Kang S; Kim W
    PLoS One; 2016; 11(3):e0150460. PubMed ID: 26954019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of the 4D fingerprint method with a robust scoring function for scaffold-hopping and drug repurposing strategies.
    Hamza A; Wagner JM; Wei NN; Kwiatkowski S; Zhan CG; Watt DS; Korotkov KV
    J Chem Inf Model; 2014 Oct; 54(10):2834-45. PubMed ID: 25229183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic assessment of scaffold distances in ChEMBL: prioritization of compound data sets for scaffold hopping analysis in virtual screening.
    Li R; Bajorath J
    J Comput Aided Mol Des; 2012 Oct; 26(10):1101-9. PubMed ID: 22972561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Scaffold hopping in drug discovery using inductive logic programming.
    Tsunoyama K; Amini A; Sternberg MJ; Muggleton SH
    J Chem Inf Model; 2008 May; 48(5):949-57. PubMed ID: 18457387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug repositioning in cancer: The current situation in Japan.
    Masuda T; Tsuruda Y; Matsumoto Y; Uchida H; Nakayama KI; Mimori K
    Cancer Sci; 2020 Apr; 111(4):1039-1046. PubMed ID: 31957175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Scaffold repositioning of spiro-acridine derivatives as fungi chitinase inhibitor by target fishing and in vitro studies.
    de Oliveira Viana J; Silva E Souza E; Sbaraini N; Vainstein MH; Gomes JNS; de Moura RO; Barbosa EG
    Sci Rep; 2023 May; 13(1):7320. PubMed ID: 37147323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent Advances in Scaffold Hopping.
    Hu Y; Stumpfe D; Bajorath J
    J Med Chem; 2017 Feb; 60(4):1238-1246. PubMed ID: 28001064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Establishing an Analogue Based In Silico Pipeline in the Pursuit of Novel Inhibitory Scaffolds against the SARS Coronavirus 2 Papain-Like Protease.
    Hajbabaie R; Harper MT; Rahman T
    Molecules; 2021 Feb; 26(4):. PubMed ID: 33672721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug repurposing for chronic myeloid leukemia: in silico and in vitro investigation of DrugBank database for allosteric Bcr-Abl inhibitors.
    Singh VK; Chang HH; Kuo CC; Shiao HY; Hsieh HP; Coumar MS
    J Biomol Struct Dyn; 2017 Jun; 35(8):1833-1848. PubMed ID: 27353341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.